Caribou Biosciences to Present at Upcoming Investor Conferences
March 07, 2022 16:11 ET
|
Caribou Biosciences, Inc.
BERKELEY, Calif., March 07, 2022 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, announced today that Rachel...